US Patent Issued to PRESIDENT AND FELLOWS OF HARVARD COLLEGE, THE CHILDREN'S MEDICAL CENTER on April 7 for "Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases" (Massachusetts Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,479, issued on April 7, was assigned to PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, Mass.) and THE CHILDREN'S MEDICAL CENTER Corp. (Cambridge, Mass.).

"Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases" was invented by Peter Jungsoo Park (Cambridge, Mass.), Jin Kuk Kim (Cambridge, Mass.), Timothy Yu (Cambridge, Mass.) and Yu-Han Huang (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods and compositions related to the modulation of progranulin expression or activity in the brain for the treatment of neurodegenerative diseases."

The patent was filed on Mar...